納微科技(688690.SH)業績快報:2021年度淨利潤升158.75%至1.88億元
格隆匯2月25日丨納微科技(688690.SH)披露2021年度業績快報,本報吿期,公司實現營業收入4.46億元,同比增長117.74%;實現歸屬於母公司所有者的淨利潤1.88億元,同比增長158.75%;實現歸屬於母公司所有者的扣除非經常性損益的淨利潤1.72億元,同比增長172.09%。
報吿期末,公司總資產12.8億元,同比增長99.97%;歸屬於母公司的所有者權益10.42億元,同比增長94.77%。公司經營業績持續增長,財務狀況良好。
我國生物製藥產業快速發展,對性能優異、供應穩定、價格合理的國產分離純化色譜填料和層析介質產品產生了迫切需求。公司依託納米微球底層製備技術創新優勢,已積累形成較齊全的產品線、規模化生產能力和專業高效的應用技術服務能力,支撐了公司業績的快速增長。
本報吿期內公司加強重點客户的需求對接和應用技術服務,實現抗體、重組蛋白、疫苗、胰島素、造影劑等眾多新項目應用,特別是單克隆抗體生物藥的研發、中試和放大生產等各階段的項目數量都有明顯增加,帶動了公司親和層析介質、離子交換層析介質等產品的銷售額較上年有較大幅度增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.